Anika Therapeutics, Inc.: accounts_receivable
| Value | {"amount": 34682000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-09-30) |
| Status | current |
| Entity | Anika Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:02:51.542883+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/426a1bff-2b82-4f5a-acd7-776012b047d0
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-23-006687Retrieved: 2026-08-19T09:02:51.542883+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000898437/accounts-receivable/2023-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/426a1bff-2b82-4f5a-acd7-776012b047d0
History
- no predecessors — first report